Literature DB >> 18685862

Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells.

Kai-Fu Tang1, Min Chen, Jing Xie, Guan-Bin Song, Yi-Song Shi, Qi Liu, Zhe-Chuan Mei, Alexander Steinle, Hong Ren.   

Abstract

Hepatitis B virus (HBV) replicates in most tumor tissues of patients with HBV-associated hepatocellular carcinoma (HCC). In the present study, we have shown that the expression of HBV in the HCC cell lines, HepG2 and Huh7, down-regulated the expression of MHC class I-related molecule A (MICA), a ligand of the NKG2D receptor. Inhibition of HBV expression by small interference RNAs (siRNAs) in HepG2.2.15, a cell line that constitutively expresses HBV, induced up-regulation of MICA. The up-regulation of MICA increased the lysis of HepG2.2.15 cells by NK cells. Our results suggest that HBV compromises the innate immune system in HCC patients and that inhibition of HBV replication by siRNAs may enhance the antitumor immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685862     DOI: 10.1007/s00430-008-0101-6

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  24 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

2.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

3.  Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.

Authors:  Danny Ka-Ho Wong; Man-Fung Yuen; Ronnie Tung-Ping Poon; John Chi-Hang Yuen; James Fung; Ching-Lung Lai
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

4.  Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.

Authors:  Sorin Armeanu; Michael Bitzer; Ulrich M Lauer; Sascha Venturelli; Anita Pathil; Matthias Krusch; Stephan Kaiser; Jürgen Jobst; Irina Smirnow; Annika Wagner; Alexander Steinle; Helmut R Salih
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

Review 5.  Immunology of hepatitis B infection.

Authors:  Maria-Christina Jung; Gerd R Pape
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

6.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

Authors:  C Boni; A Bertoletti; A Penna; A Cavalli; M Pilli; S Urbani; P Scognamiglio; R Boehme; R Panebianco; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

8.  Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: changes during the natural history and with interferon-alpha therapy in patients with hepatitis B virus infection.

Authors:  A P Catterall; I M Murray-Lyon; A J Zuckerman; T J Harrison
Journal:  J Med Virol       Date:  1994-07       Impact factor: 2.327

9.  Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Veronika Groh; Thomas Spies; Ritsuko Kimura; Takuya Miyagi; Kiyoshi Mochizuki; Yutaka Sasaki; Norio Hayashi
Journal:  Int J Cancer       Date:  2003-04-10       Impact factor: 7.396

10.  The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

Authors:  Hashem B El-Serag; Jessica A Davila; Nancy J Petersen; Katherine A McGlynn
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

View more
  12 in total

Review 1.  Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection.

Authors:  María L Cuestas; Verónica L Mathet; José R Oubiña; Alejandro Sosnik
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

2.  Role natural killer group 2D-ligand interactions in hepatitis B infection.

Authors:  Teresa Pollicino; Lemonica Koumbi
Journal:  World J Hepatol       Date:  2015-04-28

Review 3.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

4.  Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.

Authors:  Yasuteru Kondo; Osamu Kimura; Yasuhito Tanaka; Masashi Ninomiya; Tomoaki Iwata; Takayuki Kogure; Jun Inoue; Masaya Sugiyama; Tatsuki Morosawa; Yasuyuki Fujisaka; Tooru Shimosegawa
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 5.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

6.  Inhibitory effect of small interfering RNA on dengue virus replication in mosquito cells.

Authors:  Xinwei Wu; Hua Hong; Jinya Yue; Yejian Wu; Xiangzhong Li; Liyun Jiang; Lei Li; Qiaoyan Li; Guoquan Gao; Xia Yang
Journal:  Virol J       Date:  2010-10-14       Impact factor: 4.099

7.  Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.

Authors:  Kaku Goto; Dorcas A Annan; Tomoko Morita; Wenwen Li; Ryosuke Muroyama; Yasuo Matsubara; Sayaka Ito; Ryo Nakagawa; Yasushi Tanoue; Masahisa Jinushi; Naoya Kato
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 8.  The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.

Authors:  Anita Schuch; Alexander Hoh; Robert Thimme
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

Review 9.  The Role of Immune Cells in Chronic HBV Infection.

Authors:  Hai-Jun Li; Nai-Cui Zhai; Hong-Xiao Song; Yang Yang; An Cui; Tian-Yang Li; Zheng-Kun Tu
Journal:  J Clin Transl Hepatol       Date:  2015-12-15

10.  Hepatitis B viral replication influences the expression of natural killer cell ligands.

Authors:  Lemonica Koumbi; Teresa Pollicino; Giovanni Raimondo; Naveenta Kumar; Peter Karayiannis; Salim I Khakoo
Journal:  Ann Gastroenterol       Date:  2016-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.